All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MPN Advocates Network
Activated IL-6 signaling: A novel therapeutic target for CALR-mutated MPN
Mutations of the calreticulin gene (CALRmut) are driver mutations known in the development of myeloproliferative neoplasms (MPN).
EHA2021 abstracts: What’s hot in MPN?
To help navigate the exciting content being presented at the EHA2021 Virtual Congress, the MPN Hub Steering Committee members have provided their recommendations for the top abstracts to look out for in MPN, in...
"In the MPN Hub, we have gathered the most recent and most relevant information about MPN pathophysiology, clinical advances, and therapy. You are sure to find a response to your burning questions about MPN here!"